144 related articles for article (PubMed ID: 3493296)
1. Experimental strategies and interpretations in the analysis of changes in MHC gene expression during tumour progression. Opposing influences of T cell and natural killer mediated resistance?
Ljunggren HG; Kärre K
J Immunogenet; 1986; 13(2-3):141-51. PubMed ID: 3493296
[TBL] [Abstract][Full Text] [Related]
2. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
Ljunggren HG; Kärre K
J Exp Med; 1985 Dec; 162(6):1745-59. PubMed ID: 3877776
[TBL] [Abstract][Full Text] [Related]
3. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
Yamasaki T; Moritake K; Klein G
J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
[TBL] [Abstract][Full Text] [Related]
4. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
[TBL] [Abstract][Full Text] [Related]
5. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.
Ljunggren HG; Ohlén C; Höglund P; Yamasaki T; Klein G; Kärre K
J Immunol; 1988 Jan; 140(2):671-8. PubMed ID: 3335786
[TBL] [Abstract][Full Text] [Related]
6. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
Plata F; Lilly F
J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
[TBL] [Abstract][Full Text] [Related]
7. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules.
Kusunoki Y; Kyoizumi S; Honma M; Kubo Y; Ohnishi H; Hayashi T; Seyama T
J Immunol; 2000 Oct; 165(7):3555-63. PubMed ID: 11034355
[TBL] [Abstract][Full Text] [Related]
8. Natural resistance against tumors grafted into the brain in association with histocompatibility-class-I-antigen expression.
Yamasaki T; Akiyama Y; Fukuda M; Kimura Y; Moritake K; Kikuchi H; Ljunggren HG; Kärre K; Klein G
Int J Cancer; 1996 Jul; 67(3):365-71. PubMed ID: 8707410
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target.
Höglund P; Glas R; Ohlén C; Ljunggren HG; Kärre K
J Exp Med; 1991 Aug; 174(2):327-34. PubMed ID: 1856626
[TBL] [Abstract][Full Text] [Related]
10. Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells.
Carlow DA; Payne U; Hozumi N; Roder JC; Czitrom AA
Eur J Immunol; 1990 Apr; 20(4):841-6. PubMed ID: 2347364
[TBL] [Abstract][Full Text] [Related]
11. Hybrid resistance against a natural killer (NK) cell-resistant lymphoma (YWA) is mediated by a T cell-dependent mechanism.
Grönberg A; Klein GO; Kärre K; Kiessling R; Klein G
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):183-90. PubMed ID: 7201394
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Gorelik E; Jay G; Kwiatkowski B; Herberman RB
J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
[TBL] [Abstract][Full Text] [Related]
13. Differential effects on T cell and NK cell development by tissue-specific expression of H-2D(d) transgene.
Johansson MH; Bieberich C; Kâse-Sjöström A; Yoshioka T; Höglund E; Christy BA; Scangos G; Kärre K; Jay G; Höglund P
Eur J Immunol; 2000 Feb; 30(2):525-33. PubMed ID: 10671208
[TBL] [Abstract][Full Text] [Related]
14. MHC-I antigen expression determines sensitivity of hematopoetic progenitor cells as targets for NK cells.
Meyer D; Schubert J; Scholz C; Braun S; Schmidt RE
Immunobiology; 1997 Nov; 197(5):494-504. PubMed ID: 9413748
[TBL] [Abstract][Full Text] [Related]
15. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
Rembecki RM; Bennett M; Kumar V; Potter TA
J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
[TBL] [Abstract][Full Text] [Related]
16. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.
Höglund P; Ljunggren HG; Ohlén C; Ahrlund-Richter L; Scangos G; Bieberich C; Jay G; Klein G; Kärre K
J Exp Med; 1988 Oct; 168(4):1469-74. PubMed ID: 3171481
[TBL] [Abstract][Full Text] [Related]
17. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
18. MHC gene control of the natural killer system at the level of the target and the host.
Kärre K
Semin Cancer Biol; 1991 Oct; 2(5):295-309. PubMed ID: 1773046
[TBL] [Abstract][Full Text] [Related]
19. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains.
Höglund P; Glas R; Ménard C; Kåse A; Johansson MH; Franksson L; Lemmonier F; Kärre K
Eur J Immunol; 1998 Jan; 28(1):370-8. PubMed ID: 9485216
[TBL] [Abstract][Full Text] [Related]
20. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
Kumar V; Luevano E; Bennett M
J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
